Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology.
Personalized cancer therapy with selective kinase inhibitors: an emerging paradigm in medical oncology. J Clin Oncol. 2009 Nov 20; 27(33):5650-9.
View in:
PubMed
subject areas
Clinical Trials as Topic
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Resistance, Neoplasm
Female
Forecasting
Gene Targeting
Genetic Predisposition to Disease
Genome, Human
Humans
Lung Neoplasms
Male
Medical Oncology
Neoplasms
Patient Selection
Pharmacogenetics
Prognosis
Protein Kinase Inhibitors
Risk Assessment
Survival Analysis
Treatment Outcome